MyLungCancerTeam

That's a big milestone — one month on Tabrecta (capmatinib)! The bloodwork on May 26 is a really important step. Your care team will use it to check how your body is responding to the medication and monitor for any side effects.

Tabrecta is a targeted therapy that works by blocking MET proteins, which can drive tumor Show Full Answer

That's a big milestone — one month on Tabrecta (capmatinib)! The bloodwork on May 26 is a really important step. Your care team will use it to check how your body is responding to the medication and monitor for any side effects.

Tabrecta is a targeted therapy that works by blocking MET proteins, which can drive tumor growth in metastatic non-small cell lung cancer (NSCLC) with MET gene changes.

Some things your bloodwork may help monitor include:

- How well your organs (like liver and kidneys) are handling the medication
- Blood cell counts
- Any early signs of side effects that may need managing

It's a good idea to note any symptoms you've been experiencing before your appointment, so you can share them with your oncologist. Even small changes are worth mentioning!

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Lung Cancer Treatment Options